NAD+激酶
化学
烟酰胺腺嘌呤二核苷酸
烟酰胺
磁化转移
生物合成
烟酰胺单核苷酸
立体化学
生物化学
酶
医学
放射科
磁共振成像
作者
Festus Slade,Daisy Villano,Jierong Luo,Dario Livio Longo,Joanna F. Collingwood
摘要
Abstract Background The Chemical Exchange Saturation Transfer (CEST) MRI properties of six metabolites required for synthesis of coenzyme nicotinamide adenine dinucleotide (NAD+) and to evaluate the potential for clinical imaging of altered NAD+ regulation in neurodegenerative disorders Method CEST images of metabolites in the NAD+ biosynthesis pathway were acquired at physiological temperature with high‐field MRI (9.4T) running a modified magnetisation transfer (MTR) prepared RARE sequence over a range of saturation powers and frequency ofsets, for pH values 5.5‐7.4. CEST data were fitted using spline interpolation, the exchange rate was calculated, and frequency specific MTR maps were generated using pixelwise analysis. Result Tryptophan, nicotinamide, nicotinic acid (NA), nicotinamide riboside (NR), nicotinamide mononucleotide (NMN) and NADH were evaluated. At pH 7.4, all molecules exhibited CEST contrast between 0.1 and 0.9 ppm, originating from the OH hydroxyl proton. NADH exhibited up to 15% CEST contrast in a B1 field of 2.4µT from its fast‐exchanging amine groups at 2 and 3 ppm, and showed a positive dependence of CEST efciency on pH. Tryptophan exhibited three independent peaks at 0.7, 2.6, and 5.4 ppm corresponding to pH 6.7, 5.5 and 7.4. NMN showed high CEST contrast at 0.7ppm originating from its phosphorous OH enabling higher CEST efciency due to enhanced charge delocalisation (Fig.1). Conclusion This in vitro feasibility study demonstrates signal detection and characterization of NAD+ biosynthesis pathway precursor molecules over precise temperature, concentration and physiological pH ranges. All molecules exhibited a peak at 0.7 from the hydroxyl group with NMN showing highest CEST efficiency due to phosphate charge delocalisation. NADH showed a peak at 2 and 3ppm from amine group protons and a dependency on temperature and pH.
科研通智能强力驱动
Strongly Powered by AbleSci AI